Impact of EGFR tyrosine kinase inhibitors in the management of brain metastases from EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC): A survival analysis.
Antonio Picone
No relevant relationships to disclose
Tindara Franchina
No relevant relationships to disclose
Alessandro Russo
No relevant relationships to disclose
Claudia Proto
No relevant relationships to disclose
Fabio Raiti
No relevant relationships to disclose
Carmelo Buda
No relevant relationships to disclose
Giuseppe Chiofalo
No relevant relationships to disclose
Giuseppa Ferraro
No relevant relationships to disclose
Maria Picciotto
No relevant relationships to disclose
Antonino Scimone
No relevant relationships to disclose
Giuseppe Toscano
No relevant relationships to disclose
Mariangela Zanghì
No relevant relationships to disclose
Vincenzo Adamo
No relevant relationships to disclose